MAASTRICHT, the Netherlands—Inclisiran, a small, interfering RNA (siRNA) that targets the synthesis of PCSK9 in the liver, can be safely given to patients with and without impaired renal function, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback